Public Law 115-52: FDA Reauthorization Act of 2017

By | October 18, 2017
FDA logo

Food and Drug Administration logo.

Reauthorizes the Federal Food, Drug, and Cosmetic Act through FY2022, with changes to FDA user fees for prescription drugs, medical devices, generic drugs and biosimilars (biological products similar to ones already approved).

Official Summary

Passed House
(amended) 2017-07-12
Passed Senate
Signed by President
Became Public Law


Senate amendments:


Original sponsor: Rep. Walden, Greg [R-OR-2]

Cosponsors: Rep. Pallone, Frank, Jr. [D-NJ-6], Rep. Burgess, Michael C. [R-TX-26], Rep. Green, Gene [D-TX-29]


Passed House by voice vote.

Passed Senate:

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.